Your browser doesn't support javascript.
loading
Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes.
Gallo, Tyler; Heise, C William; Woosley, Raymond L; Tisdale, James E; Tan, Malinda S; Gephart, Sheila M; Antonescu, Corneliu C; Malone, Daniel C.
Afiliación
  • Gallo T; Division of Clinical Data Analytics and Decision Support University of Arizona College of Medicine-Phoenix AZ.
  • Heise CW; Department of Pharmacy Practice and Science University of Arizona College of Pharmacy Phoenix AZ.
  • Woosley RL; Division of Clinical Data Analytics and Decision Support University of Arizona College of Medicine-Phoenix AZ.
  • Tisdale JE; Department of Medical Toxicology Banner-University Medical Center Phoenix Phoenix AZ.
  • Tan MS; Division of Clinical Data Analytics and Decision Support University of Arizona College of Medicine-Phoenix AZ.
  • Gephart SM; Arizona Center for Education and Research on Therapeutics Oro Valley AZ.
  • Antonescu CC; Department of Pharmacy Practice College of Pharmacy Purdue University Indianapolis IN.
  • Malone DC; Division of Clinical Pharmacology School of Medicine Indiana University Indianapolis IN.
J Am Heart Assoc ; 11(11): e024338, 2022 06 07.
Article en En | MEDLINE | ID: mdl-35656987
ABSTRACT
Background Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP risk by guiding decision making in patients at risk. CDS has been shown to decrease prescribing of high-risk medications in patients at risk of TdP, but alerts are often ignored. Other risk-management options can potentially be incorporated in TdP risk CDS. Our goal was to evaluate actions clinicians take in response to a CDS advisory that uses a modified Tisdale QT risk score and presents management options that are easily selected (eg, single click). Methods and Results We implemented an inpatient TdP risk advisory systemwide across a large health care system comprising 30 hospitals. This CDS was programmed to appear when prescribers attempted ordering medications with a known risk of TdP in a patient with a QT risk score ≥12. The CDS displayed patient-specific information and offered relevant management options including canceling offending medications and ordering electrolyte replacement protocols or ECGs. We retrospectively studied the actions clinicians took within the advisory and separated by drug class. During an 8-month period, 7794 TdP risk advisories were issued. Antibiotics were the most frequent trigger of the advisory (n=2578, 33.1%). At least 1 action was taken within the advisory window for 2700 (34.6%) of the advisories. The most frequent action taken was ordering an ECG (n=1584, 20.3%). Incoming medication orders were canceled in 793 (10.2%) of the advisories. The frequency of each action taken varied by drug class (P<0.05 for all actions). Conclusions A modified Tisdale QT risk score-based CDS that offered relevant single-click management options yielded a high action/response rate. Actions taken by clinicians varied depending on the class of the medication that evoked the TdP risk advisory, but the most frequent was ordering an ECG.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de QT Prolongado / Torsades de Pointes / Sistemas de Apoyo a Decisiones Clínicas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Am Heart Assoc Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de QT Prolongado / Torsades de Pointes / Sistemas de Apoyo a Decisiones Clínicas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Am Heart Assoc Año: 2022 Tipo del documento: Article